KRYSTIN HEPBURN: Open Payments
NPI 1437708310 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 16 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $374 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $401 |
| Iovance Biotherapeutics, Inc. | 1 | $126 |
| Janssen Biotech, Inc. | 5 | $108 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Immunocore Limited | 1 | $22 |
Products named: Amtagvi, IMFINZI, RYBREVANT, TAGRISSO, ERLEADA, KEYTRUDA QLEX, KIMMTRAK, Enhertu.
Industry payments across NC — which companies pay providers there.
